AMANDA HARRIS: Open Payments
NPI 1255805180 · ROME, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$813 in 38 payments from 14 companies in 2025. Trend: 2023 $631 · 2024 $621 · 2025 $813
Food & beverage: $813
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 12 | $257 |
| Boston Scientific Corporation | 3 | $129 |
| E.R. Squibb & Sons, L.L.C. | 4 | $73 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $62 |
| Amgen Inc. | 3 | $57 |
| Merck Sharp & Dohme LLC | 3 | $49 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $39 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $36 |
| CVRx, Inc. | 1 | $21 |
| BridgeBio Pharma, Inc. | 1 | $20 |
Products named: LEQVIO, WATCHMAN FLX, LifeVest, REPATHA, ENTRESTO, JARDIANCE, ELIQUIS, Kerendia.
Industry payments across GA — which companies pay providers there.
